FindTrial
Sign In

Evaluation of circulating tumour cells in patients with tumour free lymphnodes in oral tongue carcinoma

Evaluation of molecular expression of pre metastatic lymph nodes and to corelate with circulating tumour cells in oral tongue tumours - CTC Trail

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/041256
Enrollment
97
Registered
2022-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C029- Malignant neoplasm of tongue, unspecified

Interventions

None listed

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor
Department of Health Research
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Tongue Squamous Cell Carcinoma with no previous history of treatment other than diagnostic biopsy.

Exclusion criteria

Exclusion criteria: Second Primary Tumours ,Recurrent Tumours

Design outcomes

Primary

MeasureTime frame
Evaluation of circulating tumour cells and to compare with the molecular markers of tumour free lymphnodesTimepoint: 5ml of peripheral blood to be taken before surgery.—

Secondary

MeasureTime frame
Evaluate of circulating tumour cells and corelate with the prognosis of OTSCC patientsTimepoint: 2 year follow up—

Countries

India

Contacts

Public ContactDr Rajalakshmi

Amrita Institute of Medical Sciences

subu.amrita@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 10, 2026